A. Raiola

发表

Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant

M. Picardi, B. Rotoli, L. Luciano, 1999, Bone Marrow Transplantation.

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD

A. Ibatici, T. Lamparelli, A. Bacigalupo, 2008, Bone Marrow Transplantation.

Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression

A. Ibatici, N. Colombo, A. Signori, 2013, British journal of haematology.

Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2022, Bone Marrow Transplantation.

A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study.

P. Chiusolo, F. Ferrara, A. Bacigalupo, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab

P. Chiusolo, A. Risitano, F. Locatelli, 2020, Bone Marrow Transplantation.

Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients

L. Boni, C. Viscoli, T. Lamparelli, 2010, Transplant infectious disease : an official journal of the Transplantation Society.

BCR/ABL mRNA and the P210(BCR/ABL) protein are downmodulated by interferon-alpha in chronic myeloid leukemia patients.

G. Saglio, F. Salvatore, F. Pane, 1999, Blood.

Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO).

L. Pagano, F. Aversa, A. Bosi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Good tolerability of high dose colistin-based therapy in patients with haematological malignancies

M. Gobbi, C. Viscoli, F. Gualandi, 2017, Infection.

De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period.

C. Viscoli, A. Bacigalupo, E. Angelucci, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant

P. Chiusolo, A. Bacigalupo, E. Angelucci, 2022, Blood Cancer Journal.

Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen

P. Chiusolo, A. Vannucchi, V. De Stefano, 2020, American journal of hematology.

Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family Donors.

G. Barosi, T. Lamparelli, A. Bacigalupo, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis.

F. Salvatore, F. Pane, B. Rotoli, 1998, Blood.

Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis

J. Maciejewski, F. Salvatore, F. Pane, 1998 .

Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.

C. Viscoli, F. Frassoni, A. Bacigalupo, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

A. Ibatici, F. Frassoni, T. Lamparelli, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.

M. Sormani, C. Viscoli, F. Frassoni, 2004, Haematologica.

Steroid treatment of acute graft-versus-host disease grade I: a randomized trial

M. Sormani, P. Chiusolo, D. Massi, 2017, Haematologica.

Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation.

A. Ibatici, N. Colombo, T. Lamparelli, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

R. Fanin, F. Baron, M. Labopin, 2022, Bone Marrow Transplantation.

Human leukocyte antigen‐haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia‐free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age

R. Fanin, F. Baron, M. Labopin, 2022 .

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

M. Labopin, I. Yakoub-Agha, D. Blaise, 2022, Bone Marrow Transplantation.

Allogeneic hemopoietic stem cell transplants in patients with acute myeloid leukemia (AML) prepared with Busulfan Fludarabine (BUFLU) or Thiotepa Busulfan Fludarabine (TBF): a retrospective study.

P. Chiusolo, A. Bacigalupo, E. Angelucci, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

M. Gobbi, N. Colombo, M. Miglino, 2019, British journal of haematology.

Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia

M. Gobbi, A. Ibatici, N. Colombo, 2017, Haematologica.

Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients

P. Bruzzi, C. Viscoli, A. Bacigalupo, 2012, Infection.

Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide

R. Fanin, P. Chiusolo, A. Santoro, 2022, Bone Marrow Transplantation.

Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection

C. Viscoli, E. Angelucci, A. Raiola, 2020 .

Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

T. Lamparelli, A. Bacigalupo, M. Miglino, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type

G. Barosi, A. Ibatici, F. Frassoni, 2010, Bone Marrow Transplantation.

Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants.

F. Frassoni, T. Lamparelli, A. Bacigalupo, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of acute graft versus host disease with low dose-alternate day anti-thymocyte globulin.

T. Lamparelli, A. Bacigalupo, F. Gualandi, 2002, Haematologica.

Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia.

M. Gobbi, S. Zupo, F. Frassoni, 2007, Blood.

Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan

C. Viscoli, M. Sanguinetti, E. Angelucci, 2019, Medical mycology.

Haploidentical hemopoietic cell transplantation for myelofibrosis, in ruxolitinib era.

I. Schiavetti, A. Bacigalupo, E. Angelucci, 2022, Transplantation and cellular therapy.

Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome

N. Sacchi, A. Ibatici, C. Viscoli, 2007, Bone Marrow Transplantation.

Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2022, Bone Marrow Transplantation.

F. Frassoni, T. Lamparelli, A. Bacigalupo, 2002, Blood.

Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.

A. Bacigalupo, S. Chiodi, S. Spinelli, 2003, Haematologica.

Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft‐versus‐host disease, donor type, cytomegalovirus infections and cell dose

F. Frassoni, T. Lamparelli, A. Bacigalupo, 2001, British journal of haematology.

Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation

M. Picardi, B. Rotoli, C. Selleri, 1998, Bone Marrow Transplantation.

(1-3)-β-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections.

C. Viscoli, A. Bacigalupo, A. Raiola, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Galactomannan testing might be useful for early diagnosis of fusariosis.

M. P. Molinari, C. Viscoli, B. Posteraro, 2012, Diagnostic microbiology and infectious disease.

Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

P. Chiusolo, E. Lanino, A. Bosi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

A. Prete, A. Rambaldi, C. Girmenia, 2018, Bone Marrow Transplantation.

CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation.

T. Lamparelli, A. Bacigalupo, F. Gualandi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.

P. Bruzzi, C. Viscoli, F. Frassoni, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma

E. Angelucci, S. Sivori, M. Falco, 2022, Frontiers in Immunology.

The effect of autistic traits on disembedding and mental rotation in neurotypical women and men

S. Baron-Cohen, M. Conson, V. P. Senese, 2022, Scientific reports.

Results in Differential Effects on Apoptosis in Chronic Myelogenous Leukemia Bcr/Abl Fas-Mediated Modulation of

J. Maciejewski, F. Salvatore, F. Pane, 2013 .

Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.

L. del Vecchio, G. Rossi, B. Rotoli, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Induction of nitric oxide synthase is involved in the mechanism of Fas‐mediated apoptosis in haemopoietic cells

N. Young, B. Rotoli, C. Selleri, 1997, British journal of haematology.

Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.

M. Gobbi, A. Ibatici, A. Signori, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid Immune Reconstitution Following Unmanipulated Haploidentical BMT with Post-Transplant High Dose Cyclophosphamide

F. Frassoni, A. Bacigalupo, F. Gualandi, 2011 .

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation

P. Chiusolo, A. Signori, T. Lamparelli, 2021, Blood advances.

Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders

M. Bassetti, E. Angelucci, A. Vena, 2023, British journal of haematology.

Allogeneic Hemopoietic Stem Transplant for Patients with Idiopathic Myelofibrosis Using a Reduced Intensity Thiotepa Based Conditioning Regimen.

M. Gobbi, G. Barosi, S. Zupo, 2007 .

CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation

M. Picardi, B. Rotoli, L. Luciano, 1998, Bone Marrow Transplantation.

Pre‐transplant minimal residual disease assessment and transplant‐related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation

M. Gobbi, N. Colombo, E. Angelucci, 2021, European journal of haematology.

Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.

A. Larocca, F. Frassoni, T. Lamparelli, 2006, Haematologica.

Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.

M. Gobbi, M. Labopin, A. Ibatici, 2008, The Lancet. Oncology.

DLI after haploidentical BMT with post-transplant CY

T. Lamparelli, A. Bacigalupo, F. Gualandi, 2015, Bone Marrow Transplantation.

Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide

R. Fanin, P. Chiusolo, A. Santoro, 2022, Bone Marrow Transplantation.

Second haploidentical stem cell transplantation for primary graft failure

P. Chiusolo, A. Bacigalupo, E. Angelucci, 2020, Bone Marrow Transplantation.

Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.

R. Fanin, P. Chiusolo, A. Santoro, 2020, Blood advances.

Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.

A. Risitano, A. Ibatici, A. Signori, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low-dose interleukin-2 for treating postautologous transplant cytogenetic abnormality recurrency in a case of acute myeloid leukemia with hyperdiploidy.

M. Picardi, B. Rotoli, L. Luciano, 1998, Blood.

Expression of AC 133 , a Novel Stem Cell Marker , on Human Leukemic Blasts Lacking CD 34 2 Antigen and on a Human CD 34 1 Leukemic Cell Line : MUTZ-2

M. Picardi, B. Rotoli, L. Luciano, 1998 .

Rituximab Prophylaxis of EBV Reactivation after Alternative Donor Transplants Following Anti-Thymocyte Globulin-Based Conditioning Regimens.

A. Ibatici, F. Frassoni, T. Lamparelli, 2008 .

Rituximab Prophylaxis of EBV Reactivation after Unrelated Donor Transplants Using Anti-Thymocyte Globulin in the Conditioning Regimen.

A. Ibatici, F. Frassoni, T. Lamparelli, 2005 .

Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

R. Fanin, F. Gherlinzoni, P. Galieni, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tagraxofusp Administered Concomitantly with Intrathecal Chemotherapy in Patients with BPDCN who Either Have or are Considered High-risk to Develop CNS Disease is a Safe and Effective Treatment Strategy: An Italian Multicenter Experience

M. Riggi, E. Angelucci, A. Dominietto, 2022, Blood.

Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.

C. Viscoli, A. Signori, A. Bacigalupo, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

H. Deeg, A. Bacigalupo, F. Gualandi, 2016 .

GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT

R. Fanin, P. Chiusolo, F. Baron, 2023, Journal of Hematology & Oncology.

HLA-haploidentical transplantation for relapsed/refractory AML: better LFS with BM than with PBSC in patients ≥ 55 years of age.

R. Fanin, F. Baron, M. Labopin, 2022, American journal of hematology.

Thiotepa-based reduced intensity conditioning regimen: a 10 year follow up

A. Ibatici, F. Frassoni, T. Lamparelli, 2007, Bone Marrow Transplantation.

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

M. Labopin, P. Chevallier, D. Blaise, 2023, HemaSphere.

Post‐transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA‐mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT

R. Fanin, M. Labopin, I. Yakoub-Agha, 2022, American journal of hematology.

Haploidentical bone marrow transplants with post transplant cyclophosphamide on day + 3 + 5: The Genova protocol.

A. Bacigalupo, E. Angelucci, A. Raiola, 2022, Blood reviews.

Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography.

M. Gobbi, A. Ibatici, S. Morbelli, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Marrow cell dose is a significant predictor of outcome in patients undergoing allogeneic hematopoietic stem cell tranplantation

F. Frassoni, T. Lamparelli, A. Bacigalupo, 2000 .

Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia

M. Gobbi, A. Bacigalupo, M. Miglino, 2014, Annals of Hematology.

Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

P. Galieni, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

Does PTCY increase the risk of infections?

A. Raiola, M. Mikulska, C. Oltolini, 2023, Blood reviews.

Aggressive multiple sclerosis: a single‐centre, real‐world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab

M. Inglese, L. Roccatagliata, A. Uccelli, 2020, European journal of neurology.

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

M. Labopin, D. Blaise, A. Nagler, 2023, Journal of Hematology & Oncology.

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

M. Inglese, G. Mancardi, P. Gallo, 2020, Multiple sclerosis.

Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis

M. Inglese, G. Mancardi, G. Boffa, 2021, Multiple sclerosis.

Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: the impact of T-repleted transplant from haploidentical donors. Authors

Balletto, C. Viscoli, A. Bacigalupo, 2017 .

Ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver diseases in bone marrow transplant patients

M. Picardi, P. Muretto, B. Rotoli, 1998, Bone Marrow Transplantation.

Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci.

C. Viscoli, A. Signori, A. Bacigalupo, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.

F. Benvenuto, F. Frassoni, T. Lamparelli, 2000, Haematologica.

randomized study allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a Increased risk of leukemia relapse with high dose cyclosporine after

F. Frassoni, C. Romagnani, T. Lamparelli, 2012 .

Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant

T. Lamparelli, A. Bacigalupo, M. Miglino, 2013 .

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

M. Labopin, D. Blaise, A. Nagler, 2023, Journal of Hematology & Oncology.

HEV infection in an Italian cohort of HSCT recipients: seroprevalence and infection.

C. Viscoli, E. Angelucci, A. Raiola, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral blood vs. bone marrow for molecular monitoring of BCR‐ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients

A. Ballestrero, F. Patrone, E. Moran, 2009, International journal of laboratory hematology.

Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study

F. Benvenuto, T. Lamparelli, A. Bacigalupo, 2000, Bone Marrow Transplantation.

Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis.

C. Viscoli, A. Signori, A. Bacigalupo, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

system fungal infections

C. Viscoli, A. Bacigalupo, A. Raiola, 2013 .

Graft-versus-Host Disease Prophylaxis with Post Transplant Cyclophosphamide in Chronic Myeloid Leukemia patients undergoing Allogeneic Hematopoietic Cell Transplant from either an Unrelated or Mismatched Related Donor: a comparative study from the Chr....

I. Yakoub-Agha, D. Mclornan, L. Griškevičius, 2023, Transplantation and cellular therapy.

Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.

C. Viscoli, A. Signori, A. Bacigalupo, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Brain FDG‐PET findings in chimeric antigen receptor T‐cell therapy neurotoxicity for diffuse large B‐cell lymphoma

M. Inglese, S. Morbelli, G. Sambuceti, 2023, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin

T. Lamparelli, A. Bacigalupo, N. Sacchi, 2000, Bone Marrow Transplantation.

Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2023, HemaSphere.

Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT

M. Labopin, M. Mohty, M. Itälä-Remes, 2024, Blood advances.

Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT).

M. Labopin, M. Mohty, M. Itälä-Remes, 2024, Bone marrow transplantation.

Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients.

M. Bassetti, E. Angelucci, A. Vena, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.